Metraipolis › archive › dc_a0eb93231d46

Personalized Combination Therapy in Bladder Cancer: cAMP Modulators Synergize with 5-FU and Modulate Redox Programs — Europe PMC PMID:41749816

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41749816
DOI
10.3390/cancers18040562
License (as archived)
solo-consultazione
Archived
2026-11-06T00:35:00.108Z
SHA-256 of the archived text
772088f1597d7e74e3f2b603a74c2c2292227c08d6ea377d8f0ad815160a8511
Stable URL of this page
https://metraipolis.com/documento/dc_a0eb93231d46

How to cite

Personalized Combination Therapy in Bladder Cancer: cAMP Modulators Synergize with 5-FU and Modulate Redox Programs — Europe PMC PMID:41749816 — Europe PMC (en), https://europepmc.org/article/MED/41749816 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a0eb93231d46 (Metraipolis archive dc_a0eb93231d46, sha256 772088f1597d7e74e3f2b603a74c2c2292227c08d6ea377d8f0ad815160a8511)
BibTeX
@misc{dca0eb93231d46,
  title = {Personalized Combination Therapy in Bladder Cancer: cAMP Modulators Synergize with 5-FU and Modulate Redox Programs — Europe PMC PMID:41749816},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41749816},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a0eb93231d46; sha256 772088f1597d7e74e3f2b603a74c2c2292227c08d6ea377d8f0ad815160a8511},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41749816. Agents can read the archived copy with the MCP tool read_document.